Tubingen, Germany

Peter Bauer

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter Bauer

Introduction

Peter Bauer is an accomplished inventor based in Tübingen, Germany. He has made significant contributions to the field of medical research, particularly in the development of treatments for complex diseases. His innovative approach has led to the creation of a patent that holds promise for addressing critical health issues.

Latest Patents

Peter Bauer holds a patent titled "Use of lyso-Gb1 as druggable target." This invention relates to the in vitro use of lyso-Gb1 as a target in the development of a drug. The patent focuses on the use of antagonists of lyso-Gb1 for the treatment and prevention of diseases such as Gaucher disease and Parkinson's disease. This work highlights the potential of targeting lyso-Gb1 in therapeutic applications.

Career Highlights

Peter Bauer is currently associated with Centogene GmbH, a company known for its focus on genetic research and rare diseases. His role at Centogene has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research initiatives. His dedication to advancing medical science is evident in his innovative work.

Collaborations

Peter Bauer has worked alongside Claudia Cozma, a fellow researcher at Centogene GmbH. Their collaboration has fostered an environment of innovation and has led to significant advancements in their respective fields.

Conclusion

Peter Bauer's contributions to medical research through his patent and work at Centogene GmbH exemplify the impact of innovation in addressing complex health challenges. His dedication to finding solutions for diseases like Gaucher and Parkinson's disease is commendable and highlights the importance of continued research in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…